Hi Ezq
”….PromarkerD test in predicting diabetic kidney disease was “published”today in journal PLOS ONE…”
I don’t recall being previously advised that it was actually published in PLOS ONE a highly regarded peer-reviewed open access journal.
This exposure is phenomenal.
The publication is quite an in-depth look at PromarkerD & available for all to read.
Ann: Clinical Utility Study demonstrates PromarkerD test benefits, page-6
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
70.0¢ |
Change
0.005(0.72%) |
Mkt cap ! $91.70M | |||
| Open | High | Low | Value | Volume |
| 70.5¢ | 71.0¢ | 69.3¢ | $130.6K | 187.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12941 | 69.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 71.0¢ | 6320 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |